Hyderabad Not too long after the delisting episode of Shanta Biotech’s pentavalent hepatitis B vaccine Shan5, the World Health Organization (WHO) has now suspended the supply of hepatitis B vaccine (Revac-B+) manufactured by Bharat Biotech International (BBIL). It has also terminated the prequalification procedures for current applications for other vaccines from Bharat Biotech International.